[Federal Register Volume 91, Number 142 (Monday, July 27, 2026)]
[Notices]
[Page 46944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-15064]
[[Page 46944]]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1515]
Certain Dermatological Treatment Devices and Components Thereof
II; Notice of Institution of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on June 22, 2026, under section 337
of the Tariff Act of 1930, as amended, on behalf of Serendia, LLC of
Los Angeles, California. Supplements were filed on July 6 and 13, 2026.
The complaint, as supplemented, alleges violations of section 337 based
upon the importation into the United States, the sale for importation,
and the sale within the United States after importation of certain
dermatological treatment devices and components thereof by reason of
the infringement of certain claims of U.S. Patent No. 9,320,536 (``the
'536 patent''); U.S. Patent No. 9,775,774 (``the '774 patent''); U.S.
Patent No. 10,869,812 (``the '812 patent''); and U.S. Patent No.
12,220,549 (``the '549 patent''). The complaint, as supplemented,
further alleges that an industry in the United States exists as
required by the applicable Federal Statute.
The complainant requests that the Commission institute an
investigation and, after the investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, may be viewed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. Hearing impaired individuals are advised that
information on this matter can be obtained by contacting the
Commission's TDD terminal on (202) 205-1810.
Persons with mobility impairments who will need special assistance
in gaining access to the Commission should contact the Office of the
Secretary at (202) 205-2000. General information concerning the
Commission may also be obtained by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Lisa Barton, The Office of the
Secretary, Docket Services Division, U.S. International Trade
Commission, telephone (202) 205-1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, 19
U.S.C. 1337, and in section 210.10 of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10 (2025).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on July 22, 2026, Ordered That--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain products
identified in paragraph (2) by reason of infringement of one or more of
claims 1-8, 11-13, and 16-18 of the '536 patent; claims 13 and 14 of
the '774 patent; claims 2-6, 8, 9, 13-16, and 18 of the '812 patent;
and claims 1-18 of the '549 patent, and whether an industry in the
United States exists as required by subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10(b)(1), the plain language
description of the accused products or category of accused products,
which defines the scope of the investigation, is ``RF microneedling
dermatological treatment devices and components thereof, including the
consoles, handpieces, and needle tips'';
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainant is: Serendia, LLC, 3660 Wilshire Blvd., Suite
504, Los Angeles, CA 90010.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
InMode Ltd., Tavor Building, Shaar Yokneam, P.O. Box 533, Yokneam
2069206, Israel.
Invasix Inc., 17 Hughes, Irvine, CA 92618.
BTL Industries, Inc., 362 Elm Street, Suite 5, Marlborough, MA
01752.
BTL Industries Limited, 161 Cleveland Way, Hertfordshire, Stevenage
SG1 6BU, England, United Kingdom.
BTL Industries JSC, Ul. Tsar Kaloyan 8, Et. 2, 1000 Sofia,
Bulgaria.
BTL Healthcare Technologies A/S, Stepanska 535/6, 12000 Prague,
Czech Republic.
BTL Enterprise Group A/S, Stepanska 535/6, 12000 Prague, Czech
Republic.
BTL Medical Technologies S.R.O. Evropska 423/178, 16000 Prague,
Czech Republic.
BTL Holding Limited, Spyrou Kyprianoy 38, 4154 Limassol, Cyprus.
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
The Office of Unfair Import Investigations will not participate as
a party in this investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: July 22, 2026.
Sharon Bellamy,
Supervisory and Hearings and Information Officer.
[FR Doc. 2026-15064 Filed 7-24-26; 8:45 am]
BILLING CODE 7020-02-P